MARKET

PHVS

PHVS

Pharvaris N.V.
NASDAQ
34.01
+0.71
+2.13%
After Hours: 34.01 0 0.00% 17:45 06/26 EDT
OPEN
33.53
PREV CLOSE
33.30
HIGH
34.06
LOW
32.93
VOLUME
519.30K
TURNOVER
--
52 WEEK HIGH
35.33
52 WEEK LOW
16.72
MARKET CAP
2.36B
P/E (TTM)
-10.7318
1D
5D
1M
3M
1Y
5Y
1D
Pharvaris Shareholders Approve 2025 Accounts and Renew Board Authorities at 2026 AGM
TipRanks · 6h ago
Pharvaris shareholders adopt Dutch statutory annual accounts for FY2025
PUBT · 7h ago
Robust RAPIDe-3 Deucrictibant Data Might Change The Case For Investing In Pharvaris (PHVS)
Simply Wall St · 16h ago
Pharvaris Is Maintained at Overweight by Morgan Stanley
Dow Jones · 1d ago
Morgan Stanley Maintains Overweight on Pharvaris, Raises Price Target to $46
Benzinga · 1d ago
Analyst Reiterates Buy on Deucrictibant’s Strong HAE Profile and Lifts Price Target to $46
TipRanks · 1d ago
Pharvaris price target raised to $46 from $41 at Morgan Stanley
TipRanks · 1d ago
Pharvaris CMO Lu Peng disposes of 300 shares worth $10,200
PUBT · 3d ago
More
About PHVS
Pharvaris NV is a Netherlands-based company primarily engaged in the biopharmaceutical industry. The Company focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. It is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The Company is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.

Webull offers Pharvaris NV stock information, including NASDAQ: PHVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHVS stock methods without spending real money on the virtual paper trading platform.